Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Toluene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 6/20 | 0.69 |
| ▸ | TSHR | P16473 | 2/20 | 0.69 |
| ▸ | LMNA | P02545 | 1/20 | 0.69 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.69 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | KIF11 | P52732 | 2/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Toluene SCHEMBL11296763 | 0.88 | TSHR (0.61) | ACHETSHRLMNAALOX12TAAR1 | |
| Toluene SCHEMBL2566607 | 0.83 | — | — | |
| Toluene SCHEMBL2508427 | 0.83 | — | — | |
| Toluene SCHEMBL10989418 | 0.83 | — | — | |
| Toluene SCHEMBL175861 | 0.83 | ACHE (1.00) | ACHETSHRLMNAALOX12HPGD | |
| Toluene SCHEMBL4429042 | 0.83 | ACHE (1.00) | ACHETSHRLMNAALOX12HPGD | |
| Toluene SCHEMBL1 | 0.83 | — | — | |
| SCHEMBL12344943 | 0.83 | ACHE (1.00) | ACHETSHRLMNAALOX12HPGD | |
| Toluene SCHEMBL8824270 | 0.83 | ACHE (1.00) | ACHETSHRLMNAALOX12HPGD | |
| Toluene SCHEMBL8938900 | 0.83 | ACHE (1.00) | ACHETSHRLMNAALOX12HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2142508-A2 | PROCESS FOR THE PREPARATION OF SODIUM SALT OF L-(((L(R)-(3-(2-(7-CHLORO-2- QUINOLINYL)-ETHENYL)PHENYL)-3-(2-(L-HYDROXY-L- METHYLETHYL)PHENYL)PROPYL)SULFANYL)METHYL)CYCLOPROPANEACETIC ACID | Zaklady Farmaceutyczne "Polpharma" S.A. (PL) | 2010-01-13 | — | — | EP | claimed |
| WO-2008136693-A2 | PROCESS FOR THE PREPARATION OF SODIUM SALT OF L-(((L(R)-(3-(2-(7-CHLORO-2- QUINOLINYL)-ETHENYL)PHENYL)-3-(2-(L-HYDROXY-L- METHYLETHYL)PHENYL)PROPYL)SULFANYL)METHYL)CYCLOPROPANEACETIC ACID | ZAKLADY FARMACEUTYCZNE POLPHARMA SA (PL) | 2008-11-13 | — | — | WO | claimed |
| US-20260117617-A1 | EXPANDABLE POLYMER GROUT FOR SAND CONTROL IN A WELL | CHEVRON USA INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-12612839-B1 | Expandable polymer grout for sand control in a well | CHEVRON U.S.A. INC. (US) | 2026-04-28 | — | — | US | disclosed |
| EP-3898205-B1 | SURFACE TREATMENT TO ENHANCE BONDING OF COMPOSITE MATERIALS | CYTEC IND INC (US) | 2026-03-11 | — | — | EP | disclosed |
| US-20260063011-A1 | EXPANDABLE POLYMER GROUT FOR WELLBORE APPLICATIONS | CHEVRON USA INC (US) | 2026-03-05 | — | — | US | disclosed |
| US-12428931-B2 | Cement top jobs in wellbore annuli using expandable compositions | CHEVRON U.S.A. INC. (US) | 2025-09-30 | — | — | US | disclosed |
| US-20250250878-A1 | EXPANDABLE POLYMER GROUT FOR SEALING SUBTERRANEAN FORMATIONS | CHEVRON U.S.A. INC. | 2025-08-07 | — | — | US | disclosed |
| US-12378842-B1 | Expandable polymer grout for sealing subterranean formations | CHEVRON U.S.A. INC. (US) | 2025-08-05 | — | — | US | disclosed |
| US-12134950-B2 | Deployment methods for expandable polymer grout for plug and abandonment applications | CHEVRON U.S.A. INC. (US) | 2024-11-05 | — | — | US | disclosed |
| US-20240191594-A1 | Cement Top Jobs In Wellbore Annuli Using Expandable Compositions | CHEVRON U.S.A. INC. | 2024-06-13 | — | — | US | disclosed |
| EP-2142508-A2 | PROCESS FOR THE PREPARATION OF SODIUM SALT OF L-(((L(R)-(3-(2-(7-CHLORO-2- QUINOLINYL)-ETHENYL)PHENYL)-3-(2-(L-HYDROXY-L- METHYLETHYL)PHENYL)PROPYL)SULFANYL)METHYL)CYCLOPROPANEACETIC ACID | Zaklady Farmaceutyczne "Polpharma" S.A. (PL) | 2010-01-13 | — | — | EP | disclosed |
| WO-2009091909-A2 | DEGRADABLE NON-AQUEOUS GEL SYSTEMS | M-I L.L.C. (US) | 2009-07-23 | — | — | WO | disclosed |
| WO-2008147641-A1 | ISOCYANATE-EPOXY FORMULATIONS FOR IMPROVED CURE CONTROL | DOW GLOBAL TECHNOLOGIES INC. (US) | 2008-12-04 | — | — | WO | disclosed |
| WO-2008136693-A2 | PROCESS FOR THE PREPARATION OF SODIUM SALT OF L-(((L(R)-(3-(2-(7-CHLORO-2- QUINOLINYL)-ETHENYL)PHENYL)-3-(2-(L-HYDROXY-L- METHYLETHYL)PHENYL)PROPYL)SULFANYL)METHYL)CYCLOPROPANEACETIC ACID | ZAKLADY FARMACEUTYCZNE POLPHARMA SA (PL) | 2008-11-13 | — | — | WO | disclosed |
| WO-2008134359-A1 | USE OF ELASTOMERS TO PRODUCE GELS FOR TREATING A WELLBORE | M-I LLC (US) | 2008-11-06 | — | — | WO | disclosed |
| EP-1669385-A1 | Continuous method for manufacturing an acid functional blocked solid isocyanate | Bayer MaterialScience LLC (US) | 2006-06-14 | — | — | EP | disclosed |
| US-20060122357-A1 | Continuous method for manufacturing an acid functional blocked solid isocyanate | BAYER MATERIALSCIENCE LLC | 2006-06-08 | — | — | US | disclosed |
| US-6762322-B1 | CYCLIZING IMINE GROUP TO OXAZIRIDINE RING USING PEROXYSULFATE OXIDIZING AGENT AND REARRANGING TO OXIME FUNCTIONALITY | GOODYEAR TIRE & RUBBER COMPANY | 2004-07-13 | — | — | US | disclosed |
| US-20040122225-A1 | PREPARATION OF NITRONE DERIVATIVES | THE GOODYEAR TIRE & RUBBER COMPANY | 2004-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040122225-A1 | PREPARATION OF NITRONE DERIVATIVES | NOX5, NDUFS5, NDUFS8 | ACHE 2586/4885TSHR 3431/4885LMNA 698/4885 |
| US-20260063011-A1 | EXPANDABLE POLYMER GROUT FOR WELLBORE APPLICATIONS | HPSE, HIRIP3, WEE2 | ACHE 2827/4885TSHR 4686/4885LMNA 3559/4885 |
| US-12612839-B1 | Expandable polymer grout for sand control in a well | GET3, USE1, WEE2 | ACHE 1815/4885TSHR 4839/4885LMNA 1332/4885 |
| US-20260117617-A1 | EXPANDABLE POLYMER GROUT FOR SAND CONTROL IN A WELL | GET3, WEE1, WEE2 | ACHE 1710/4885TSHR 4849/4885LMNA 1413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.